BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 10.67% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 8.68% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 7.12% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 6.58% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.76% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.48% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 4.29% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 3.86% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 3.79% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 3.79% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.57% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 3.42% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.35% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.25% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.22% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 2.79% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 2.54% |
| ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 2.09% |
| PRME | Prime Medicine, Inc. Common Stock | Healthcare | Biotechnology | 1.88% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 1.72% |